article thumbnail

Tools for Paying Medical Bills Don’t Help Health Consumers Manage Their Financial Health

Health Populi

There’s a gap between the supply of digital health tools that hospitals and health systems offer patients, and what patients-as-consumers need for overall health and wellbeing. This chasm is illustrated in The future of the digital patient experience , the latest report from HIMSS and the Center for Connected Medicine (CCM).

article thumbnail

Pharma’s Future Relevance Depends on Empathy, Messaging, Partnering, and Supporting Patients and Providers

Health Populi

in May and June 2020. Top-line, Accenture points to four pillars on which the pharma industry can “reinvent its relevance,” as the report title suggests: To express greater empathy, understanding the patient experience of delaying treatment, financial impacts, and mental health challenges the pandemic has caused.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Wellness in 2023 Is About Connections, Mental Health and Science – Global Wellness Summit’s 2023 Trends

Health Populi

trillion in 2020, as the bubble chart illustrates. Whether looking at biotech beauty and what “clean” really means, effectively dealing with obesity, or biohacking our biology, wellness-engaged health citizens are not interesting in the shiny new thing without data backing up claims.

article thumbnail

Andreessen Horowitz : how the next generation of Bio and Healthcare companies will be built

Lloyd Price

Four years ago, when we launched our first bio fund, the idea that software would make an impact in drug discovery sounded like science fiction; the idea it could transform the patient experience in healthcare a fool’s errand. Tech, biotech, and our healthcare system are merging—into what we call simply “bio”.

BioTech 81
article thumbnail

Digital Health Technologies in Clinical Trials

Digital Health Global

in 2020, with projections suggesting up to 70% of clinical trials incorporating wearable sensors by 2025. The company will supply solutions to AstraZeneca while extending services to pharma, biotech companies, and clinical research organizations. In a recent review paper appeared on Nature , Mittermaier et al. in 2010 to 11.4%